Cargando…

Deoxynybomycins inhibit mutant DNA gyrase and rescue mice infected with fluoroquinolone-resistant bacteria

Fluoroquinolones are one of the most commonly prescribed classes of antibiotics, but fluoroquinolone resistance (FQR) is widespread and increasing. Deoxynybomycin (DNM) is a natural-product antibiotic with an unusual mechanism of action, inhibiting the mutant DNA gyrase that confers FQR. Unfortunate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parkinson, Elizabeth I., Bair, Joseph S., Nakamura, Bradley A., Lee, Hyang Y., Kuttab, Hani I., Southgate, Emma H., Lezmi, Stéphane, Lau, Gee W., Hergenrother, Paul J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Pub. Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421842/ https://www.ncbi.nlm.nih.gov/pubmed/25907309 http://dx.doi.org/10.1038/ncomms7947

Ejemplares similares

Suppression of gyrase-mediated resistance by C7 aryl fluoroquinolones
por: Malik, Muhammad, et al.
Publicado: (2016)

Impact of Amino Acid Substitutions in B Subunit of DNA Gyrase in Mycobacterium leprae on Fluoroquinolone Resistance
por: Yokoyama, Kazumasa, et al.
Publicado: (2012)

Bypassing Fluoroquinolone Resistance with Quinazolinediones: Studies of Drug–Gyrase–DNA Complexes Having Implications for Drug Design
por: Drlica, Karl, et al.
Publicado: (2014)

Alternations in DNA gyrase genes in low-level fluoroquinolone-resistant Moraxella catarrhalis strains isolated in Poland
por: Król-Turmińska, Katarzyna, et al.
Publicado: (2018)

Targeting Bacterial Gyrase with Cystobactamid, Fluoroquinolone, and Aminocoumarin Antibiotics Induces Distinct Molecular Signatures in Pseudomonas aeruginosa
por: Franke, Raimo, et al.
Publicado: (2021)

Experimental and Molecular Docking Studies of Cyclic Diphenyl Phosphonates as DNA Gyrase Inhibitors for Fluoroquinolone-Resistant Pathogens
por: Saleh, Neveen M., et al.
Publicado: (2022)

Spiropyrimidinetriones: a Class of DNA Gyrase Inhibitors with Activity against Mycobacterium tuberculosis and without Cross-Resistance to Fluoroquinolones
por: Basarab, Gregory S., et al.
Publicado: (2022)

Mycobacterium fluoroquinolone resistance protein B, a novel small GTPase, is involved in the regulation of DNA gyrase and drug resistance
por: Tao, Jun, et al.
Publicado: (2013)

Characterization of DNA Gyrase Activity and Elucidation of the Impact of Amino Acid Substitution in GyrA on Fluoroquinolone Resistance in Mycobacterium avium
por: Thapa, Jeewan, et al.
Publicado: (2023)

The Structural Modeling of the Interaction between Levofloxacin and the Mycobacterium tuberculosis Gyrase Catalytic Site Sheds Light on the Mechanisms of Fluoroquinolones Resistant Tuberculosis in Colombian Clinical Isolates
por: Alvarez, N., et al.
Publicado: (2014)

Genome-wide mapping of fluoroquinolone-stabilized DNA gyrase cleavage sites displays drug specific effects that correlate with bacterial persistence
por: Tang, Juechun, et al.
Publicado: (2023)

DNA supercoiling differences in bacteria result from disparate DNA gyrase activation by polyamines
por: Duprey, Alexandre, et al.
Publicado: (2020)

Clinically Relevant Mutant DNA Gyrase Alters Supercoiling, Changes the Transcriptome, and Confers Multidrug Resistance
por: Webber, Mark A., et al.
Publicado: (2013)

Single-molecule dynamics of DNA gyrase in evolutionarily distant bacteria Mycobacterium tuberculosis and Escherichia coli
por: Galvin, Cooper J., et al.
Publicado: (2023)

Solution structures of DNA-bound gyrase
por: Baker, Nicole M., et al.
Publicado: (2011)

DNA Gyrase as a Target for Quinolones
por: Spencer, Angela C., et al.
Publicado: (2023)

The balance between gyrase and topoisomerase I activities determines levels of supercoiling, nucleoid compaction, and viability in bacteria
por: García-López, Míriam, et al.
Publicado: (2023)

Discovery of a Novel Mutation in DNA Gyrase and Changes in the Fluoroquinolone Resistance of Helicobacter pylori over a 14-Year Period: A Single Center Study in Korea
por: Rhie, Su Yeon, et al.
Publicado: (2020)

1787. County Level Association Between the Rate of Fluoroquinolone-Resistance Gram Negative Bacteria and Fluoroquinolone Utilization in Kansas
por: Fulmer, Robert D, et al.
Publicado: (2022)

Cardiac Arrhythmia Following an Epileptic Seizure
por: Kuttab, Hani I., et al.
Publicado: (2019)

Vibrio cholerae ParE2 Poisons DNA Gyrase via a Mechanism Distinct from Other Gyrase Inhibitors
por: Yuan, Jie, et al.
Publicado: (2010)

Characterization of Mutations in DNA Gyrase and Topoisomerase IV in Field Strains and In Vitro Selected Quinolone-Resistant Mycoplasma hyorhinis Mutants
por: Li, Jun, et al.
Publicado: (2022)

Global Evolution of Pathogenic Bacteria With Extensive Use of Fluoroquinolone Agents
por: Fuzi, Miklos, et al.
Publicado: (2020)

High-throughput assays for DNA gyrase and other topoisomerases
por: Maxwell, Anthony, et al.
Publicado: (2006)

Inhibition of translesion DNA polymerase by archaeal reverse gyrase
por: Valenti, Anna, et al.
Publicado: (2009)

The role of monovalent cations in the ATPase reaction of DNA gyrase
por: Hearnshaw, Stephen James, et al.
Publicado: (2015)

Recognition of DNA Supercoil Geometry by Mycobacterium tuberculosis Gyrase
por: Ashley, Rachel E., et al.
Publicado: (2017)

Activities of gyrase and topoisomerase IV on positively supercoiled DNA
por: Ashley, Rachel E., et al.
Publicado: (2017)

Inhibitory Compounds Targeting Plasmodium falciparum Gyrase B
por: Pakosz, Zuzanna, et al.
Publicado: (2021)

Fluoroquinolone-resistant Streptococcus pneumoniae
por: Pletz, Mathias W.R., et al.
Publicado: (2006)

The comparison of clinical outcomes of endophthalmitis from fluoroquinolone-resistant and susceptible bacteria
por: Shirodkar, Anita R, et al.
Publicado: (2010)

Implementation of permeation rules leads to a FabI inhibitor with activity against Gram-negative pathogens
por: Parker, Erica N., et al.
Publicado: (2019)

Ribosome Rescue Pathways in Bacteria
por: Müller, Claudia, et al.
Publicado: (2021)

Bacteria and Sepsis: Microbiome to the Rescue?
por: Kang, Hansol, et al.
Publicado: (2021)

Fragments of the Bacterial Toxin Microcin B17 as Gyrase Poisons
por: Collin, Frédéric, et al.
Publicado: (2013)

The role of Ca(2+) in the activity of Mycobacterium tuberculosis DNA gyrase
por: Karkare, Shantanu, et al.
Publicado: (2012)

DNA Gyrase Is the Target for the Quinolone Drug Ciprofloxacin in Arabidopsis thaliana
por: Evans-Roberts, Katherine M., et al.
Publicado: (2016)

Identification of novel bacterial DNA gyrase inhibitors: An in silico study
por: Rahimi, Hamzeh, et al.
Publicado: (2016)

Direct observation of helicase–topoisomerase coupling within reverse gyrase
por: Yang, Xi, et al.
Publicado: (2020)

Properties of Plasmodium falciparum with a Deleted Apicoplast DNA Gyrase
por: Tan, SooNee, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qqdl80d0q41f439t9iim0hepam